97 related articles for article (PubMed ID: 4367595)
21. Antiviral effect of 3-[bis-(2-hydroxyethyl)-amino]-acetophenone-[4,5-diphenyl-oxyazolyl-(2)]hydrazone (IMET 98/69) in mice.
Veckenstedt A; Indulen MK; Dzeguse D; Zgórniak-Nowosielska I; Mécs I; Béládi I
Acta Virol; 1979 Nov; 23(6):500-3. PubMed ID: 44666
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of symmetrical 1,5-bisacyloxyanthraquinone derivatives and their dual activity of cytotoxicity and lipid peroxidation.
Huang HS; Chiu HF; Chiou JF; Yeh PF; Tao CW; Jeng WR
Arch Pharm (Weinheim); 2002 Dec; 335(10):481-6. PubMed ID: 12506396
[TBL] [Abstract][Full Text] [Related]
23. Antiviral and cytotoxic effects of mycophenolic acid.
Planterose DN
J Gen Virol; 1969 Jun; 4(4):629-30. PubMed ID: 4308492
[No Abstract] [Full Text] [Related]
24. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and cytostatic activity of some sulfamido-anthraquinones.
Teijeira M; Santana L; Uriarte E; Jorge ML; Seoane R
Farmaco; 1996 Jun; 51(6):447-50. PubMed ID: 8766230
[TBL] [Abstract][Full Text] [Related]
26. Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones.
Zee-Cheng RK; Mathew AE; Xu PL; Northcutt RV; Cheng CC
J Med Chem; 1987 Sep; 30(9):1682-6. PubMed ID: 3625713
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
[TBL] [Abstract][Full Text] [Related]
29. New trends in synthesis of pyrazole nucleosides as new antimetabolites.
Elgemeie GH; Zaghary WA; Amin KM; Nasr TM
Nucleosides Nucleotides Nucleic Acids; 2005; 24(8):1227-47. PubMed ID: 16270665
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapeutics. 7. Chemotherapy of bacterial infections. Chemotherapy of protozoan infections. Chemotherapy of virus infections].
Mayr E
Pharm Prax; 1967; 7():163-93. PubMed ID: 4893524
[No Abstract] [Full Text] [Related]
31. Peculiarities of the antiviral action of dibenzylphosphinic acid.
Inglot AD; Kochman M; Mastalerz P; Pelczarska A
Acta Virol; 1967 May; 11(3):199-205. PubMed ID: 4382472
[No Abstract] [Full Text] [Related]
32. Antiviral activity of the sodium salt of 1,1,3,3-tetracyanopropene.
Grunberg E; Prince HN
Antimicrob Agents Chemother (Bethesda); 1967; 7():642-5. PubMed ID: 5596202
[No Abstract] [Full Text] [Related]
33. Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives.
Morreal CE; Bernacki RJ; Hillman M; Atwood A; Cartonia D
J Med Chem; 1990 Feb; 33(2):490-2. PubMed ID: 2299618
[TBL] [Abstract][Full Text] [Related]
34. Enantioselective total synthesis and structure determination of the antiherpetic anthrapyran antibiotic AH-1763 IIa.
Tietze LF; Gericke KM; Singidi RR
Angew Chem Int Ed Engl; 2006 Oct; 45(42):6990-3. PubMed ID: 17009355
[No Abstract] [Full Text] [Related]
35. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
[TBL] [Abstract][Full Text] [Related]
36. Anthraquinones As Pharmacological Tools and Drugs.
Malik EM; Müller CE
Med Res Rev; 2016 Jul; 36(4):705-48. PubMed ID: 27111664
[TBL] [Abstract][Full Text] [Related]
37. Association between chemical structure and antiviral activity of biguanide, sulfonylurethane, and sulfonamide derivatives.
Denys A; Machlanński T; Arnold Z
Acta Microbiol Pol A; 1973; 5(3):212-5. PubMed ID: 4769559
[No Abstract] [Full Text] [Related]
38. Synthesis and antineoplastic evaluation of 1,4-bis(aminoalkanamido)-9,10-anthracenediones.
Martelli S; Dzieduszycka M; Stefanska B; Bontemps-Gracz M; Borowski E
J Med Chem; 1988 Oct; 31(10):1956-9. PubMed ID: 3172129
[TBL] [Abstract][Full Text] [Related]
39. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic compounds: patent evaluation of WO2011011652A1.
Supuran CT
Expert Opin Ther Pat; 2011 Sep; 21(9):1491-5. PubMed ID: 21548842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
